QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line

The anti-proliferative activities of Novel series of 2-(4-fluorophenyl) imidazol-5-ones against MCF-7 breast cancer cell line were explored via in-slico studies which includes Quantitative structure–activity relationship QSAR, molecular docking studies, designing new compounds, and analyzing the pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawal, Hadiza Abdulrahman, Uzairu, Adamu, Uba, Sani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704527/
https://www.ncbi.nlm.nih.gov/pubmed/33247393
http://dx.doi.org/10.1007/s10863-020-09858-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704527/
https://www.ncbi.nlm.nih.gov/pubmed/33247393
http://dx.doi.org/10.1007/s10863-020-09858-0

Ejemplares similares